The Ohio State University
Siltuximab reduces severity of cytokine release syndrome, ICANS after CAR T-cell therapy
Siltuximab effectively treated patients who experienced common adverse events after chimeric antigen receptor T-cell therapy, according to findings published in Blood Advances.
40% of people treated with chemotherapy develop persistent, severe nerve pain
Chronic chemotherapy-induced peripheral neuropathy is a substantial burden among people with cancer treated with chemotherapy, according to results of a systematic review and meta-analysis published in Regional Anesthesia & Pain Medicine.
Patient, surgical factors may impact failure, outcomes after shoulder instability surgery
KOLOA, Hawaii — Launched in 2011, the Multicenter Orthopedic Outcomes Network Shoulder Instability Group, also known as the MOON study group, aimed to determine predictors of failure and poor outcomes after surgery for shoulder instability.
VIDEO: Use the biceps for anterior cable reconstruction of irreparable rotator cuff tears
KOLOA, Hawaii — In this video from Orthopedics Today Hawaii, Julie Y. Bishop, MD, spoke about using a biceps tendon graft for anterior cable reconstruction in patients with irreparable rotator cuff tears.
Community-engaged intervention reduces polysubstance overdose deaths by 37%
A community coalition-engaged intervention led to a statistically significant reduction in overdose deaths involving any opioid and psychostimulants other than cocaine, according to a study published in JAMA Network Open.
EHR can help automate biosimilar selection, streamline prior authorization
An electronic health record tool has demonstrated the potential to automate the selection of biosimilars.
‘Be very suspicious’: Staging of early pancreatic cancer inaccurate up to 80% of the time
Nearly 80% of individuals clinically diagnosed with stage I pancreatic ductal adenocarcinoma and close to 30% diagnosed with stage II disease got upstaged after surgery, according to retrospective study results.
Gut microbiome may contribute to cognitive problems after chemotherapy
Chemotherapy-induced changes to the gut microbiome may explain why some patients with cancer experience post-chemotherapy cognitive decline.
Christopher C. Kaeding, MD, announced as president of AOSSM
The American Orthopaedic Society for Sports Medicine announced Christopher C. Kaeding, MD, as president at the AOSSM Annual Meeting, according to a press release.
Clinic designed to minimize autoimmune effects of immunotherapy treatment
A new clinic at The Ohio State University — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Pelotonia Institute for Immuno-Oncology seeks to minimize the autoimmune effects of immunotherapy cancer treatment.